Morsang sur Orge, France

Jean Claude Muller


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Morsang s/Orge, FR (1994 - 1995)
  • Morsang Sur Orge, FR (1990 - 1997)

Company Filing History:


Years Active: 1990-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Jean Claude Muller: Innovator in Cerebral Disorder Treatments

Introduction

Jean Claude Muller is a notable inventor based in Morsang sur Orge, France. His work has significantly contributed to the field of pharmaceuticals, particularly focusing on compounds aimed at treating cerebral disorders. With a total of seven patents to his name, Muller has showcased a commitment to innovation in his field.

Latest Patents

Muller's most recent inventions include two impactful patents:

1. **N-(3-Aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide** - These compounds possess a specific formula that facilitates the treatment of cerebral disorders. The variable components of the compound, such as R1, R'1, R3, and R4, allow for a range of medicinal applications tailored to patient needs.

2. **N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide** - Similar to the first, this compound formula also underscores the potential in treating cerebral disorders, leveraging the structural variations in its chemical composition.

Career Highlights

As an inventor at Synthelabo, Muller has harnessed his expertise to advance pharmacological solutions. His contributions have not only enriched the company's portfolio but have also paved the way for new therapies that address critical health issues related to brain function.

Collaborations

Throughout his career, Muller has collaborated with esteemed colleagues such as Paul Howard Williams and Jonathan Reid Frost. These partnerships have fostered an environment of shared knowledge and innovation, further enhancing the research and development efforts within Synthelabo.

Conclusion

Jean Claude Muller stands out as an influential figure in the realm of pharmaceutical innovations, particularly in treating cerebral disorders. His ongoing dedication to research and collaboration continues to drive significant advancements in medical science, promising a healthier future for individuals affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…